Periodicity in tumor vasculature targeting kinetics of ligand-functionalized nanoparticles studied by dynamic contrast enhanced magnetic resonance imaging and intravital microscopy

被引:14
|
作者
Hak, Sjoerd [1 ,2 ,3 ]
Cebulla, Jana [2 ,3 ]
Huuse, Else Marie [1 ,2 ,3 ]
Davies, Catharina de L. [4 ]
Mulder, Willem J. M. [5 ,6 ]
Larsson, Henrik B. W. [2 ,7 ]
Haraldseth, Olav [1 ,2 ,3 ,8 ]
机构
[1] Norwegian Univ Sci & Technol, MI Lab, N-7034 Trondheim, Norway
[2] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, N-7034 Trondheim, Norway
[3] Inst Sirkulasjon & Bildediagnost, MR Senteret, N-7491 Trondheim, Norway
[4] Norwegian Univ Sci & Technol, Dept Phys, N-7034 Trondheim, Norway
[5] Icahn Sch Med Mt Sinai, Translat & Mol Imaging Inst, New York, NY USA
[6] Mt Sinai Sch Med, New York, NY 10029 USA
[7] Glostrup Univ Hosp, Diagnost Dept, Funct Imaging Unit, Glostrup, Denmark
[8] St Olavs Univ Hosp, Dept Med Imaging, Trondheim, Norway
关键词
DCE-MRI; Intravital microscopy; Targeted nanoparticles; Targeting kinetics; Vascular targeting; IN-VIVO; ANGIOGENESIS; INTEGRIN; LIPOSOMES; PERFUSION; PEPTIDES; EFFICACY; DTPA; MRI; T-1;
D O I
10.1007/s10456-013-9380-7
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
In the past two decades advances in the development of targeted nanoparticles have facilitated their application as molecular imaging agents and targeted drug delivery vehicles. Nanoparticle-enhanced molecular imaging of the angiogenic tumor vasculature has been of particular interest. Not only because angiogenesis plays an important role in various pathologies, but also since endothelial cell surface receptors are directly accessible for relatively large circulating nanoparticles. Typically, nanoparticle targeting towards these receptors is studied by analyzing the contrast distribution on tumor images acquired before and at set time points after administration. Although several exciting proof-of-concept studies demonstrated qualitative assessment of relative target concentration and distribution, these studies did not provide quantitative information on the nanoparticle targeting kinetics. These kinetics will not only depend on nanoparticle characteristics, but also on receptor binding and recycling. In this study, we monitored the in vivo targeting kinetics of alpha(v)beta(3)-integrin specific nanoparticles with intravital microscopy and dynamic contrast enhanced magnetic resonance imaging, and using compartment modeling we were able to quantify nanoparticle targeting rates. As such, this approach can facilitate optimization of targeted nanoparticle design and it holds promise for providing more quantitative information on in vivo receptor levels. Interestingly, we also observed a periodicity in the accumulation kinetics of alpha(v)beta(3)-integrin targeted nanoparticles and hypothesize that this periodicity is caused by receptor binding, internalization and recycling dynamics. Taken together, this demonstrates that our experimental approach provides new insights in in vivo nanoparticle targeting, which may proof useful for vascular targeting in general.
引用
收藏
页码:93 / 107
页数:15
相关论文
共 50 条
  • [1] Periodicity in tumor vasculature targeting kinetics of ligand-functionalized nanoparticles studied by dynamic contrast enhanced magnetic resonance imaging and intravital microscopy
    Sjoerd Hak
    Jana Cebulla
    Else Marie Huuse
    Catharina de L. Davies
    Willem J. M. Mulder
    Henrik B. W. Larsson
    Olav Haraldseth
    Angiogenesis, 2014, 17 : 93 - 107
  • [2] Liver transplantation: Dynamic contrast-enhanced magnetic resonance imaging of the hepatic vasculature
    Ward, J
    Spencer, JA
    Guthrie, JA
    Robinson, PJ
    CLINICAL RADIOLOGY, 1996, 51 (03) : 191 - 197
  • [3] Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging
    Choyke, PL
    Dwyer, AJ
    Knopp, MV
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2003, 17 (05) : 509 - 520
  • [4] Assessing tumor angiogenesis with dynamic contrast enhanced magnetic resonance imaging
    Esparza-Coss, Emilio
    Jackson, Edward F.
    MEDICAL PHYSICS, 2006, 854 : 19 - +
  • [5] Effect of tamoxifen in an experimental model of breast tumor studied by dynamic contrast-enhanced magnetic resonance imaging and different contrast agents
    Marzola, P
    Ramponi, S
    Nicolato, E
    Lovati, E
    Sandri, M
    Calderan, L
    Crescimanno, C
    Merigo, F
    Sbarbati, A
    Grotti, A
    Vultaggio, S
    Cavagna, F
    Lorusso, V
    Osculati, F
    INVESTIGATIVE RADIOLOGY, 2005, 40 (07) : 421 - 429
  • [6] Tumor Permeability of Nanocarriers Observed by Dynamic Contrast-enhanced Magnetic Resonance Imaging
    Kawano, Kumi
    Maitani, Yoshie
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2010, 130 (12): : 1679 - 1685
  • [7] Dynamic contrast-enhanced magnetic resonance imaging of tumor interstitial fluid pressure
    Gulliksrud, Kristine
    Brurberg, Kjetil G.
    Rofstad, Einar K.
    RADIOTHERAPY AND ONCOLOGY, 2009, 91 (01) : 107 - 113
  • [8] Tumor Characterization with Dynamic Contrast Enhanced Magnetic Resonance Imaging and Biodegradable Macromolecular Contrast Agents in Mice
    Wu, Xueming
    Feng, Yi
    Jeong, Eun-Kee
    Emerson, Lyska
    Lu, Zheng-Rong
    PHARMACEUTICAL RESEARCH, 2009, 26 (09) : 2202 - 2208
  • [9] Tumor Characterization with Dynamic Contrast Enhanced Magnetic Resonance Imaging and Biodegradable Macromolecular Contrast Agents in Mice
    Xueming Wu
    Yi Feng
    Eun-Kee Jeong
    Lyska Emerson
    Zheng-Rong Lu
    Pharmaceutical Research, 2009, 26 : 2202 - 2208
  • [10] A longitudinal study of radiation-induced changes in tumor vasculature by contrast-enhanced magnetic resonance imaging
    Yu, H
    Su, MY
    Wang, ZH
    Nalcioglu, O
    RADIATION RESEARCH, 2002, 158 (02) : 152 - 158